Watanabe, M., Sowa, Y., Yogosawa, M., & Sakai, T. (2013). Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)‐reactivating agents enhance efficacy of 5‐fluorouracil on human colon cancer cells. Cancer Sci.
Chicago Style CitationWatanabe, Motoki, Yoshihiro Sowa, Mayumi Yogosawa, i Toshiyuki Sakai. "Novel MEK Inhibitor Trametinib and Other Retinoblastoma Gene (RB)‐reactivating Agents Enhance Efficacy of 5‐fluorouracil On Human Colon Cancer Cells." Cancer Sci 2013.
Cita MLAWatanabe, Motoki, Yoshihiro Sowa, Mayumi Yogosawa, i Toshiyuki Sakai. "Novel MEK Inhibitor Trametinib and Other Retinoblastoma Gene (RB)‐reactivating Agents Enhance Efficacy of 5‐fluorouracil On Human Colon Cancer Cells." Cancer Sci 2013.
Atenció: Aquestes cites poden no estar 100% correctes.